Halperin SA - Search Results

1

Induction of immunologic memory by conjugated vs plain meningococcal C polysaccharide vaccine in toddlers: a randomized controlled trial.

MacDonald NE, Halperin SA, Law BJ, Forrest B, Danzig LE, Granoff DM. MacDonald NE, et al. Among authors: halperin sa. JAMA. 1998 Nov 18;280(19):1685-9. doi: 10.1001/jama.280.19.1685. JAMA. 1998. PMID: 9832000 Clinical Trial.

2

Immunization with Haemophilus influenzae type b polysaccharide vaccine at 18 and 24 months of age: evidence of decreased immunogenicity.

Adderson EE, Chisholm N, Halperin SA. Adderson EE, et al. Among authors: halperin sa. Clin Invest Med. 1991 Aug;14(4):338-45. Clin Invest Med. 1991. PMID: 1782732

3

Safety and immunogenicity of two acellular pertussis vaccines with different pertussis toxoid and filamentous hemagglutinin content in infants 2-6 months old.

Halperin SA, Eastwood B, Barreto L, Mills E, Blatter M, Reisinger K, Bader G, Keyserling H, Roberts EA, Guasparini R, et al. Halperin SA, et al. Scand J Infect Dis. 1995;27(3):279-87. doi: 10.3109/00365549509019022. Scand J Infect Dis. 1995. PMID: 8539554 Clinical Trial.

4

Acellular pertussis vaccine as a booster dose for seventeen- to nineteen-month-old children immunized with either whole cell or acellular pertussis vaccine at two, four and six months of age.

Halperin SA, Mills E, Barreto L, Pim C, Eastwood BJ. Halperin SA, et al. Pediatr Infect Dis J. 1995 Sep;14(9):792-7. doi: 10.1097/00006454-199509000-00012. Pediatr Infect Dis J. 1995. PMID: 8559630 Clinical Trial.

5

Adverse reactions and antibody response to four doses of acellular or whole cell pertussis vaccine combined with diphtheria and tetanus toxoids in the first 19 months of life.

Halperin SA, Eastwood BJ, Barreto L, Friesen B, Medd L, Meekison W, Guasparini R. Halperin SA, et al. Vaccine. 1996 Jun;14(8):767-72. doi: 10.1016/0264-410x(95)00250-5. Vaccine. 1996. PMID: 8817823 Clinical Trial.

6

Effect of inactivated poliovirus vaccine on the antibody response to Bordetella pertussis antigens when combined with diphtheria-pertussis-tetanus vaccine.

Halperin SA, Langley JM, Eastwood BJ. Halperin SA, et al. Clin Infect Dis. 1996 Jan;22(1):59-62. doi: 10.1093/clinids/22.1.59. Clin Infect Dis. 1996. PMID: 8824967 Clinical Trial.

7

Safety and immunogenicity of an acellular pertussis diphtheria tetanus vaccine given as a single injection with Haemophilus influenzae b conjugate vaccine.

Halperin SA, Barreto L, Eastwood BJ, Medd L, Guasparini R, Mills E. Halperin SA, et al. Vaccine. 1997 Feb;15(3):295-300. doi: 10.1016/s0264-410x(96)00177-6. Vaccine. 1997. PMID: 9139489 Clinical Trial.

8

Estimates of the effectiveness of a whole-cell pertussis vaccine from an outbreak in an immunized population.

Bentsi-Enchill AD, Halperin SA, Scott J, MacIsaac K, Duclos P. Bentsi-Enchill AD, et al. Among authors: halperin sa. Vaccine. 1997 Feb;15(3):301-6. doi: 10.1016/s0264-410x(96)00176-4. Vaccine. 1997. PMID: 9139490

9

Extended follow-up of antibody levels and antigen responsiveness after 2 Haemophilus influenzae type b conjugate vaccines.

Scheifele DW, Halperin SA, Guasparini R, Meekison W, Pim C, Barreto L. Scheifele DW, et al. Among authors: halperin sa. J Pediatr. 1999 Aug;135(2 Pt 1):240-5. doi: 10.1016/s0022-3476(99)70028-4. J Pediatr. 1999. PMID: 10431120 Clinical Trial.

10

Safety and immunogenicity of Haemophilus influenzae-tetanus toxoid conjugate vaccine given separately or in combination with a three-component acellular pertussis vaccine combined with diphtheria and tetanus toxoids and inactivated poliovirus vaccine for the first four doses.

Halperin SA, King J, Law B, Mills E, Willems P. Halperin SA, et al. Clin Infect Dis. 1999 May;28(5):995-1001. doi: 10.1086/514741. Clin Infect Dis. 1999. PMID: 10452624 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results